Literature DB >> 15316651

Phosphinic peptides as zinc metalloproteinase inhibitors.

V Dive1, D Georgiadis, M Matziari, A Makaritis, F Beau, P Cuniasse, A Yiotakis.   

Abstract

Solid-phase synthesis of phosphinic peptides was introduced 10 years ago. A major application of this chemistry has been the development of potent synthetic inhibitors of zinc metalloproteases. Specific properties of the inhibitors produced in recent years are reviewed, supporting the notion that phosphinic pseudo-peptides are useful tools for studying the structural and functional biology of zinc proteases.

Mesh：

Substances：

Year:  2004        PMID： 15316651     DOI： 10.1007/s00018-004-4050-y

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN： 1420-682X            Impact factor:   9.261


  104 in total

1.  Position paper on the management of patients with obstructive sleep apnea and hypertension: joint recommendations by the European Society of Hypertension, by the European Respiratory Society and by the members of European COST (COoperation in Scientific and Technological research) ACTION B26 on obstructive sleep apnea.

Authors:  Gianfranco Parati; Carolina Lombardi; Jan Hedner; Maria R Bonsignore; Ludger Grote; Ruzena Tkacova; Patrick Levy; Renata Riha; Claudio Bassetti; Krzysztof Narkiewicz; Giuseppe Mancia; Walter T McNicholas
Journal:  J Hypertens       Date:  2012-04       Impact factor: 4.844

Review 2.  Adaptive servoventilation for treatment of sleep-disordered breathing in heart failure: a systematic review and meta-analysis.

Authors:  Bhavneesh K Sharma; Jessie P Bakker; David G McSharry; Akshay S Desai; Shahrokh Javaheri; Atul Malhotra
Journal:  Chest       Date:  2012-11       Impact factor: 9.410

3.  Low efficacy of atrial fibrillation ablation in severe obstructive sleep apnoea patients.

Authors:  Maria Matiello; Mercé Nadal; David Tamborero; Antonio Berruezo; Josep Montserrat; Cristina Embid; Jose Rios; Julián Villacastín; Josep Brugada; Lluís Mont
Journal:  Europace       Date:  2010-05-20       Impact factor: 5.214

4.  Cheyne-Stokes respiration and prognosis in congestive heart failure.

Authors:  S Andreas; G Hagenah; C Moller; G S Werner; H Kreuzer
Journal:  Am J Cardiol       Date:  1996-12-01       Impact factor: 2.778

5.  Prognostic value of nocturnal Cheyne-Stokes respiration in chronic heart failure.

Authors:  P A Lanfranchi; A Braghiroli; E Bosimini; G Mazzuero; R Colombo; C F Donner; P Giannuzzi
Journal:  Circulation       Date:  1999-03-23       Impact factor: 29.690

6.  A 10-year follow-up of snoring in men.

Authors:  E Lindberg; A Taube; C Janson; T Gislason; K Svärdsudd; G Boman
Journal:  Chest       Date:  1998-10       Impact factor: 9.410

7.  Sleep-disordered breathing in patients with atrial fibrillation and normal systolic left ventricular function.

Authors:  Thomas Bitter; Christoph Langer; Jürgen Vogt; Mathias Lange; Dieter Horstkotte; Olaf Oldenburg
Journal:  Dtsch Arztebl Int       Date:  2009-03-06       Impact factor: 5.594

8.  Obstructive sleep apnea and the recurrence of atrial fibrillation.

Authors:  Ravi Kanagala; Narayana S Murali; Paul A Friedman; Naser M Ammash; Bernard J Gersh; Karla V Ballman; Abu S M Shamsuzzaman; Virend K Somers
Journal:  Circulation       Date:  2003-05-12       Impact factor: 29.690

9.  Pulmonary capillary wedge pressure and pulmonary arterial pressure in heart failure patients with sleep-disordered breathing.

Authors:  Olaf Oldenburg; Thomas Bitter; Marcus Wiemer; Christoph Langer; Dieter Horstkotte; Cornelia Piper
Journal:  Sleep Med       Date:  2009-01-08       Impact factor: 3.492

10.  Clinical outcome endpoints in heart failure trials: a European Society of Cardiology Heart Failure Association consensus document.

Authors:  Faiez Zannad; Angeles Alonso Garcia; Stefan D Anker; Paul W Armstrong; Gonzalo Calvo; John G F Cleland; Jay N Cohn; Kenneth Dickstein; Michael J Domanski; Inger Ekman; Gerasimos S Filippatos; Mihai Gheorghiade; Adrian F Hernandez; Tiny Jaarsma; Joerg Koglin; Marvin Konstam; Stuart Kupfer; Aldo P Maggioni; Alexandre Mebazaa; Marco Metra; Christina Nowack; Burkert Pieske; Ileana L Piña; Stuart J Pocock; Piotr Ponikowski; Giuseppe Rosano; Luis M Ruilope; Frank Ruschitzka; Thomas Severin; Scott Solomon; Kenneth Stein; Norman L Stockbridge; Wendy Gattis Stough; Karl Swedberg; Luigi Tavazzi; Adriaan A Voors; Scott M Wasserman; Holger Woehrle; Andrew Zalewski; John J V McMurray
Journal:  Eur J Heart Fail       Date:  2013-06-19       Impact factor: 15.534
View more
  18 in total

Review 1.  Matrix metalloproteinase inhibitors: a critical appraisal of design principles and proposed therapeutic utility.

Authors:  György Dormán; Sándor Cseh; István Hajdú; László Barna; Dénes Kónya; Krisztina Kupai; László Kovács; Péter Ferdinandy
Journal:  Drugs       Date:  2010-05-28       Impact factor: 9.546

2.  Predicted seminal astacin-like protease is required for processing of reproductive proteins in Drosophila melanogaster.

Authors:  Kristipati Ravi Ram; Laura K Sirot; Mariana F Wolfner
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-20       Impact factor: 11.205

3.  Discovery of Selective Inhibitors of Endoplasmic Reticulum Aminopeptidase 1.

Authors:  Zachary Maben; Richa Arya; Digamber Rane; W Frank An; Shailesh Metkar; Marc Hickey; Samantha Bender; Akbar Ali; Tina T Nguyen; Irini Evnouchidou; Roger Schilling; Efstratios Stratikos; Jennifer Golden; Lawrence J Stern
Journal:  J Med Chem       Date:  2019-12-30       Impact factor: 7.446

Review 4.  Is there new hope for therapeutic matrix metalloproteinase inhibition?

Authors:  Roosmarijn E Vandenbroucke; Claude Libert
Journal:  Nat Rev Drug Discov       Date:  2014-11-07       Impact factor: 84.694

Review 5.  A modern understanding of the traditional and nontraditional biological functions of angiotensin-converting enzyme.

Authors:  Kenneth E Bernstein; Frank S Ong; Wendell-Lamar B Blackwell; Kandarp H Shah; Jorge F Giani; Romer A Gonzalez-Villalobos; Xiao Z Shen; Sebastien Fuchs; Rhian M Touyz
Journal:  Pharmacol Rev       Date:  2012-12-20       Impact factor: 25.468

6.  Interpretable correlation descriptors for quantitative structure-activity relationships.

Authors:  Benson M Spowage; Craig L Bruce; Jonathan D Hirst
Journal:  J Cheminform       Date:  2009-12-24       Impact factor: 5.514

7.  Aminopeptidase fingerprints, an integrated approach for identification of good substrates and optimal inhibitors.

Authors:  Marcin Drag; Matthew Bogyo; Jonathan A Ellman; Guy S Salvesen
Journal:  J Biol Chem       Date:  2009-11-30       Impact factor: 5.157

8.  A Bacterial Cell Shape-Determining Inhibitor.

Authors:  Yanjie Liu; Emilisa Frirdich; Jennifer A Taylor; Anson C K Chan; Kris M Blair; Jenny Vermeulen; Reuben Ha; Michael E P Murphy; Nina R Salama; Erin C Gaynor; Martin E Tanner
Journal:  ACS Chem Biol       Date:  2016-01-15       Impact factor: 5.100

9.  Phosphinic acid-based inhibitors of tubulin polyglutamylases.

Authors:  Yanjie Liu; Christopher P Garnham; Antonina Roll-Mecak; Martin E Tanner
Journal:  Bioorg Med Chem Lett       Date:  2013-05-30       Impact factor: 2.823

10.  A common single nucleotide polymorphism in endoplasmic reticulum aminopeptidase 2 induces a specificity switch that leads to altered antigen processing.

Authors:  Irini Evnouchidou; James Birtley; Sergey Seregin; Athanasios Papakyriakou; Efthalia Zervoudi; Martina Samiotaki; George Panayotou; Petros Giastas; Olivia Petrakis; Dimitris Georgiadis; Andrea Amalfitano; Emmanuel Saridakis; Irene M Mavridis; Efstratios Stratikos
Journal:  J Immunol       Date:  2012-07-25       Impact factor: 5.422
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.